Merck Co Inc MRK Secures FDA Priority Review for Keytruda Regimen Advances Terns Pharmaceuticals Acquisition Pipeline Texxon NPT Stock Balance Sheet 027 20260422 EOSE Eos Energy Q4 loss widens sharply as EPS miss of 088 crushes estimates by 382 amid cost challenges Is RenX Enterprises RENX stock worth initiating exposure Slight Dip 20260420 CRIS Curis shares gain 252 percent despite Q4 2025 EPS coming in below consensus analyst expectations US Bancorp USB Sabra SBRA Stock Risk Factors Evaluation Q4 2025 EPS Misses Views PhenixFIN PFXNZ Deep Dive Q1 2026 Earnings Fall Short